GE HealthCare Technologies GEHC PDx — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GE HealthCare Technologies in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about GE HealthCare Technologies's pdx — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is GE HealthCare Technologies's pdx — cost of sales?
- GE HealthCare Technologies (GEHC) reported pdx — cost of sales of $406M in Q1 2026.
- How has GE HealthCare Technologies's pdx — cost of sales changed year-over-year?
- GE HealthCare Technologies's pdx — cost of sales increased by 38.1% year-over-year, from $294M to $406M.
- What is the long-term trend for GE HealthCare Technologies's pdx — cost of sales?
- Over 3 years (2022 to 2025), GE HealthCare Technologies's pdx — cost of sales has grown at a 13.0% compound annual growth rate (CAGR), from $1.01B to $1.45B.
- What does pdx — cost of sales mean?
- Includes the direct costs associated with manufacturing and distributing contrast media and diagnostic agents, such as raw materials, labor, and production overhead. This metric is a primary indicator of the segment's direct production efficiency and supply chain cost management.